Anna Lasota
Family Medicine · Emporia, KSNPI 1407175573
Payments from drug & device makers
Across 149 payments — averaging $15.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$356
- Novo Nordisk$293
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$285
- Merck$145
- Amgen$142
- Lilly USA, LLC$132
- plus $970 from 26 others
What the payments were for
- Food & beverage$2,324100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 22 | $356 |
| Novo Nordisk | 22 | $293 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 18 | $285 |
| Merck | 11 | $145 |
| Amgen | 10 | $142 |
| Lilly USA, LLC | 9 | $132 |
| Pfizer | 6 | $126 |
| AstraZeneca | 7 | $97 |
| Sanofi-aventis U.S. LLC | 6 | $86 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $74 |
| Boehringer Ingelheim | 5 | $71 |
| Hologic Sales And Service, LLC | 2 | $69 |
| Ironshore Pharmaceuticals Inc. | 1 | $67 |
| Abbott | 4 | $66 |
| Dexcom, Inc. | 2 | $36 |
| Bayer | 2 | $31 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
| Smith+Nephew | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Novartis | 1 | $15 |
| Ardelyx, Inc. | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $15 |
| Insulet Corporation | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Boston Scientific | 1 | $13 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $12 |
| GSK | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
| Tris Pharma Inc | 1 | $11 |
How this compares
$2,324 in reported general payments places this provider in the 75th percentile of 1,469 family medicine providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 64 | $61,514 |
| MounjaroTirzepatide | 55 | $56,378 |
| EliquisApixaban | 59 | $43,794 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 28 | $22,180 |
| JardianceEmpagliflozin | 14 | $14,878 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $14,001 |
| TrulicityDulaglutide | 15 | $12,732 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 25 | $11,902 |
| MyrbetriqMirabegron | 15 | $11,436 |
| XareltoRivaroxaban | 11 | $5,913 |
| Fluoxetine Hcl | 35 | $2,254 |
| Pantoprazole Sodium | 135 | $1,882 |
| BreynaBudesonide/Formoterol Fumarate | 13 | $1,877 |
| Gabapentin | 139 | $1,620 |
| Duloxetine Hcl | 69 | $1,349 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $132 | $69,11070 claims |
| Novo NordiskOzempic | $293 | $61,51464 claims |
| PfizerEliquis | $126 | $43,79459 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $71 | $26,78039 claims |
| GSKTrelegy Ellipta | $12 | $22,18028 claims |
| AstraZenecaBreztri Aerosphere | $97 | $14,00116 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,469 family medicine providers in Kansas.
Other family medicine in Emporia
- Terry PolingWichita$24.2M
- Richard GloverNewton$19.6M
- Daniel DickersonLenexa$13.6M
- Patrick YaoOlathe$11.7M
- Michael RauschAugusta$8.1M
- Terry KleinWichita$5.9M
- Richard EgelhofWichita$4.1M
- Thomas KleinWichita$3.4M
- Troy HoldemanNewton$3.2M
- Stacy SlechtaNewton$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.